Antibody therapies have been approved for the treatment of cancer, immune disorders, metabolic, cardiovascular, and infectious diseases. PepTalk’s Antibody Discovery pipeline offers a forum for protein scientists who are working to discover and develop differentiated biotherapeutics for additional unmet medical needs quickly and efficiently. These programs explore smarter and higher throughput screening methods, novel discovery platforms, strategies for dealing with challenging targets and modalities, creative engineering approaches for improving the precision and efficacy of therapeutic antibodies and the increasing role of machine learning and AI in discovery and engineering. Join us to explore the important advances in this dynamic field.
January 13
Symposium: Bispecific Engineering & Therapeutics
If you are working in the following areas join the PepTalk community:
- Antibody Discovery
- Antibody Engineering
- Antibody Technologies
- Biologics Development
- Biotherapeutics Development
- Cellular Engineering
- Development
- Protein Engineering
- Protein Sciences
- Regulatory Affairs
- Research
- Translational Sciences